/Investor DB

Correlation Ventures — 2024 Investments

10 investments dated 2024 · listed companies and verified rows first · show all

Healtharchealtharc.ioin𝕏Apr 2024 · $5M

HealthArc provides a platform for Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), serving hospitals and healthcare providers.

Digital HealthHealthtechSaaS

Sudeepin

Co-investorsScOp Venture CapitalDream CapitalOriginal Capital

Momosmomos.cominSep 2024 · $10M

Momos provides AI agents for hospitality brands that automate guest relations across channels such as reviews, SMS, email, and third-party delivery, auto-resolving support tickets and generating customer experience insights.

AI & Machine LearningMarketing TechSaaS

Sai Alluri(Founder)inAndrew Liu(Founder)in

Co-investors645 VenturesAlpha Wave GlobalBrainstorm VenturesCaptii VenturesFJ LabsHOF Capital+6 more

Orchardgetorchard.comMar 2024 · $3.8M

Orchard sells premium pre-owned smartphones that pass two rounds of 30-point quality inspections, at discounts of up to 70% off new prices.

Circular EconomyConsumerE-commerce

Bruno WongAlex Sebastian(Founder)in

Co-investors500 GlobalMaple Leaf AngelsContraryGeneral CatalystGenius VenturesHumba Ventures+4 more

Overviewoverview.aiin𝕏Seed · Nov 2024

Overview.ai builds custom hardware, edge AI, and software systems that give manufacturers real-time visibility into their production processes to catch defects earlier and reduce waste.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareIoTRoboticsSan Francisco, US

Austin Appel(Founder)inRussell Nibbelink(Founder)inChristopher Van Dyke(Founder)inXiaoyang Kao(Founder)inDaniel Chen(GTM)Sarah Ham(Future COO)

Co-investorsAlumni VenturesArray Ventures Management LlcBlumberg CapitalGV (Google Ventures)HomebrewKoru Capital+13 more

Qlaris Bioqlaris.bioinMay 2024 · $24M

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.

BiotechMedical DevicesDedham, US

Thurein Htoo(Executive Officer, Director)inFred Guerard(President & Chief Executive Officer)inBarbara Wirostko(Executive Officer)

BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)

Co-investorsCanaan Partnersabrdn plcMayo Clinic VenturesNew Leaf Venture Partners

Quantilequantile.cominMar 2024 · $6Macquired by London Stock Exchange

Quantile provides portfolio compression and optimisation services that use algorithms to reduce risk, notional, margin and capital requirements for financial institutions.

Enterprise SoftwareFintech

Co-investorsSpectrum EquityFirst Round Capital

Quantile Healthquantilehealth.cominMar 2024 · $6M

Quantile Health builds Maxwell, an AI rebate agent that automates utilization management (UM) validation for healthcare rebate processing, aiming to expand patient access and reduce rebate slippage.

AI & Machine LearningDigital HealthHealthtechAlbany, US

Peter D. Hancock(Co-Founder)Andrew W. Lo(Co-Founder)Jonathan H. Gruber(Chief Policy Officer)Yutong Sun(Executive Officer, Director)Jackie Wu(Executive Officer)Sidra Ahmed(Director)

Co-investorsFirst Round CapitalMunich Re Ventures

Safiresafire.coinSep 2024 · $8M

Safire develops hardware and software for energy systems, including resilient battery design, ruggedized sensing, secure communications, and an AI-powered energy operating system for real-time monitoring and control.

CleantechDefense TechEnergyHardwareMobility & Transportation

John Lee(Founder)in

Co-investorsAutomotive Ventures MobilityDangerous VenturesHigher Life VenturesMaC Venture CapitalOUTPOST VENTURESAJINOMOTO CO.,INC.+1 more

Valora Therapeuticsvaloratherapeutics.cominJul 2024 · $30M

Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications.

BiotechHealthtechLa Jolla, US

Miguel Garcia-Guzman(Co-Founder, CEO & Director)inCarolyn Bertozzi(Scientific Co-Founder)Jessica Stark(Scientific Co-Founder)inJames Lee(VP, Business Development)in

BoardStefan Heller(Director)Sanford Madigan(Director)in

Co-investorsAvalon BioVenturesAlexandria

Zenlyticzenlytic.cominSep 2024 · $9M

Zenlytic offers an AI analyst (named Zoë) that answers business questions and generates written analyses, visualizations, and presentation decks by connecting to data warehouses like Snowflake, BigQuery, and Databricks.

AI & Machine LearningData & InfrastructureEnterprise Software

Paul Blankley(Founder)inRyan Janssen(Founder)

Co-investors14Peaks CapitalBain Capital VenturesHabitat PartnersM13Primary Venture PartnersCompany Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.